QQQ   306.49 (-0.74%)
AAPL   156.77 (-0.95%)
MSFT   273.51 (-1.04%)
META   200.29 (-1.26%)
GOOGL   100.90 (-1.52%)
AMZN   97.60 (-0.45%)
TSLA   188.57 (-1.69%)
NVDA   262.03 (-1.24%)
NIO   9.14 (+2.35%)
BABA   95.86 (+11.31%)
AMD   93.48 (-3.24%)
T   18.86 (-0.05%)
F   11.62 (+0.87%)
MU   58.40 (-2.32%)
CGC   1.87 (-0.53%)
GE   93.00 (-0.33%)
DIS   95.46 (-0.17%)
AMC   4.65 (+2.20%)
PFE   40.12 (-0.25%)
PYPL   72.53 (-1.05%)
NFLX   326.47 (-0.36%)
QQQ   306.49 (-0.74%)
AAPL   156.77 (-0.95%)
MSFT   273.51 (-1.04%)
META   200.29 (-1.26%)
GOOGL   100.90 (-1.52%)
AMZN   97.60 (-0.45%)
TSLA   188.57 (-1.69%)
NVDA   262.03 (-1.24%)
NIO   9.14 (+2.35%)
BABA   95.86 (+11.31%)
AMD   93.48 (-3.24%)
T   18.86 (-0.05%)
F   11.62 (+0.87%)
MU   58.40 (-2.32%)
CGC   1.87 (-0.53%)
GE   93.00 (-0.33%)
DIS   95.46 (-0.17%)
AMC   4.65 (+2.20%)
PFE   40.12 (-0.25%)
PYPL   72.53 (-1.05%)
NFLX   326.47 (-0.36%)
QQQ   306.49 (-0.74%)
AAPL   156.77 (-0.95%)
MSFT   273.51 (-1.04%)
META   200.29 (-1.26%)
GOOGL   100.90 (-1.52%)
AMZN   97.60 (-0.45%)
TSLA   188.57 (-1.69%)
NVDA   262.03 (-1.24%)
NIO   9.14 (+2.35%)
BABA   95.86 (+11.31%)
AMD   93.48 (-3.24%)
T   18.86 (-0.05%)
F   11.62 (+0.87%)
MU   58.40 (-2.32%)
CGC   1.87 (-0.53%)
GE   93.00 (-0.33%)
DIS   95.46 (-0.17%)
AMC   4.65 (+2.20%)
PFE   40.12 (-0.25%)
PYPL   72.53 (-1.05%)
NFLX   326.47 (-0.36%)
QQQ   306.49 (-0.74%)
AAPL   156.77 (-0.95%)
MSFT   273.51 (-1.04%)
META   200.29 (-1.26%)
GOOGL   100.90 (-1.52%)
AMZN   97.60 (-0.45%)
TSLA   188.57 (-1.69%)
NVDA   262.03 (-1.24%)
NIO   9.14 (+2.35%)
BABA   95.86 (+11.31%)
AMD   93.48 (-3.24%)
T   18.86 (-0.05%)
F   11.62 (+0.87%)
MU   58.40 (-2.32%)
CGC   1.87 (-0.53%)
GE   93.00 (-0.33%)
DIS   95.46 (-0.17%)
AMC   4.65 (+2.20%)
PFE   40.12 (-0.25%)
PYPL   72.53 (-1.05%)
NFLX   326.47 (-0.36%)
NASDAQ:ADXS

Ayala Pharmaceuticals - ADXS News Today

$1.27
-0.04 (-2.90%)
(As of 03/28/2023 10:45 AM ET)
Add
Compare
Today's Range
$1.20
▼
$1.31
50-Day Range
N/A
52-Week Range
$1.00
▼
$10.40
Volume
6,168 shs
Average Volume
7,581 shs
Market Capitalization
$2.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Ayala Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADXS and its competitors with MarketBeat's FREE daily newsletter.


ADXS Media Mentions By Week

ADXS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADXS
News Sentiment
▼
0.00

0.60
▲
Average
Medical
News Sentiment

ADXS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADXS Articles
This Week
▼
0

0
▲
ADXS Articles
Average Week

No headlines for this company have been tracked by MarketBeat.com

Get Ayala Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADXS and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ADXS) was last updated on 3/28/2023 by MarketBeat.com Staff